Medicare Access and CHIP Reauthorization Act of 2015

Payments to specialists could yo-yo under MIPSAvalere conducted an analysis to assess the effect of MIPS. Here are the surprising results.
Health policy experts predict election outcome, healthcare changesWhile healthcare has flown under the radar for much of this election season, it’s a topic that was not ignored at the Academy of Managed Care Pharmacy (AMCP) Nexus in National Harbor, Maryland.
CMS grants docs reprieve from MACRA implementationHere’s how you can take advantage of this breathing room.
Medicare payment reform threatens independent practice
Medicare payment reform threatens independent practiceCritics of MACRA fear MIPS’s extensive reporting requirements, and physicians who choose the APM route may be signing the death warrant for their practices.
Value-Based Payment program presents potential ramificationsOphthalmologists need to prepare their practices for the Value-Based Payment (VBP) program for Medicare services. VBP is a strategy to promote quality and value of health care services, with providers being paid based on value-of-care-delivered rather than volume. Regardless of the perspectives, the fact remains that reimbursement can increase or decrease substantially with the VBP program.
Eleven ways MACRA will impact your businessWhat impact will MACRA have on your organization? We asked experts to tell us.
How to make value-based care more valuableHere are the top 3 value-based healthcare developments of 2015 and the top 3 ways to advance value-based care in 2016.
What will healthcare look like in three years?During their headline session at the AMCP conference, presenters from Avalere Health shared their predictions for "three futures" in the healthcare market.
How the SGR repeal will impact managed care
How the SGR repeal will impact managed careExperts weigh in on what to expect as provisions of the Medicare Access and CHIP Reauthorization Act roll out.
Physicians left in Meaningful Use limboThe MGMA, among others representing medical practices, is asking CMS to delay the Stage 3 rules of meaningful use to benefit physicians and patients.